Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06267183
Status:
RECRUITING
Last Update Posted:
2024-02-20
First Post:
2024-02-01
Brief Title:
A Clinical Study to Evaluate Safety Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers
Sponsor:
Shanghai Synvida Biotechnology CoLtd
Organization:
Shanghai Synvida Biotechnology CoLtd
Study Overview
Official Title:
A Phase I Single-center Randomized Double-blind Single-dose Dose-ascending Placebo-controlled Clinical Study to Evaluate Safety Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate safety tolerability PK and immunogenicity of SV001 compare to placebo in Chinese healthy adult volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None